GoldenGolden
Advanced Search
Aro Biotherapeutics

Aro Biotherapeutics

Aro Biotherapeutics is a protein Scaffolds.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

January 2021
Aro Biotherapeutics raises a $88,000,000 series A round from BVF Partners, BioMotiv, Cowen Healthcare Investments, HealthCap, Ionis Pharmaceuticals, Johnson & Johnson Development Corporation, Northpond Ventures and Ridgeback Capital.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.